Search Results - "Fumitaka Suzuki"

Impact of sodium glucose cotransporter 2 inhibitor on histological features and glucose metabolism of non‐alcoholic fatty liver disease complicated by diabetes mellitus by Akuta, Norio, Kawamura, Yusuke, Watanabe, Chizuru, Nishimura, Akihiro, Okubo, Minoru, Mori, Yasumichi, Fujiyama, Shunichiro, Sezaki, Hitomi, Hosaka, Tetsuya, Kobayashi, Masahiro, Kobayashi, Mariko, Saitoh, Satoshi, Suzuki, Fumitaka, Suzuki, Yoshiyuki, Arase, Yasuji, Ikeda, Kenji, Kumada, Hiromitsu

“…Aim The aim of this study was to investigate the therapeutic potential of sodium glucose cotransporter 2 inhibitor (SGLT2I) as an effective therapeutic option…”
Get full text

Correlation between serum hepatitis B virus core-related antigen and intrahepatic covalently closed circular DNA in chronic hepatitis B patients by Suzuki, Fumitaka, Miyakoshi, Hideo, Kobayashi, Mariko, Kumada, Hiromitsu

“…Nucleos(t)ide analogues are utilized for the treatment of chronic HBV infection, and HBe seroconversion and HBV DNA levels are commonly used as markers of…”
Get full text

Japan Society of Hepatology Guidelines for the Management of Hepatitis B Virus Infection: 2019 update

“…The Drafting Committee for Hepatitis Management Guidelines established by the Japan Society of Hepatology published the first version of the Guidelines for the…”
Get full text

SGLT2 Inhibitor Treatment Outcome in Nonalcoholic Fatty Liver Disease Complicated with Diabetes Mellitus: The Long-term Effects on Clinical Features and Liver Histopathology by Akuta, Norio, Kawamura, Yusuke, Fujiyama, Shunichiro, Sezaki, Hitomi, Hosaka, Tetsuya, Kobayashi, Masahiro, Kobayashi, Mariko, Saitoh, Satoshi, Suzuki, Fumitaka, Suzuki, Yoshiyuki, Arase, Yasuji, Ikeda, Kenji, Kumada, Hiromitsu

“…Objective The aim of this study was to determine the long-term effects of a sodium-glucose cotransporter 2 inhibitor (SGLT2i) in nonalcoholic fatty liver…”
Get full text

Direct-Acting Antivirals Decreased Tumor Recurrence After Initial Treatment of Hepatitis C Virus-Related Hepatocellular Carcinoma by Ikeda, Kenji, Kawamura, Yusuke, Kobayashi, Masahiro, Kominami, Yoko, Fujiyama, Shunichiro, Sezaki, Hitomi, Hosaka, Tetsuya, Akuta, Norio, Saitoh, Satoshi, Suzuki, Fumitaka, Suzuki, Yoshiyuki, Arase, Yasuji, Kumada, Hiromitsu

“…Background Suppressive activity of recurrence by interferon-free direct-acting antivirals (DAA) is not elucidated after curative treatment of hepatocellular…”
Get full text

Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection by Kumada, Hiromitsu, Watanabe, Tsunamasa, Suzuki, Fumitaka, Ikeda, Kenji, Sato, Ken, Toyoda, Hidenori, Atsukawa, Masanori, Ido, Akio, Takaki, Akinobu, Enomoto, Nobuyuki, Kato, Koji, Alves, Katia, Burroughs, Margaret, Redman, Rebecca, Pugatch, David, Pilot-Matias, Tami J., Krishnan, Preethi, Oberoi, Rajneet K., Xie, Wangang, Chayama, Kazuaki

“…Background Once-daily, orally administered, co-formulated glecaprevir (NS3/4A protease inhibitor) and pibrentasvir (NS5A inhibitor) (G/P) demonstrated…”
Get full text

Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis C virus infection with and without cirrhosis by Chayama, Kazuaki, Suzuki, Fumitaka, Karino, Yoshiyasu, Kawakami, Yoshiiku, Sato, Ken, Atarashi, Tomofumi, Naganuma, Atsushi, Watanabe, Tsunamasa, Eguchi, Yuichiro, Yoshiji, Hitoshi, Seike, Masataka, Takei, Yoshiyuki, Kato, Koji, Alves, Katia, Burroughs, Margaret, Redman, Rebecca, Pugatch, David L., Pilot-Matias, Tami J., Krishnan, Preethi, Oberoi, Rajneet K., Xie, Wangang, Kumada, Hiromitsu

“…Background The once-daily, all oral, RBV-free, pangenotypic direct-acting anti-viral regimen consisting of co-formulated NS3/4A protease inhibitor glecaprevir…”
Get full text

The useful predictors of zinc deficiency for the management of chronic liver disease by Iritani, Soichi, Kawamura, Yusuke, Muraishi, Nozomu, Fujiyama, Shunichiro, Sezaki, Hitomi, Hosaka, Tetsuya, Akuta, Norio, Kobayashi, Masahiro, Saitoh, Satoshi, Suzuki, Fumitaka, Arase, Yasuji, Ikeda, Kenji, Suzuki, Yoshiyuki, Kumada, Hiromitsu

“…Background Zinc deficiency is likely to occur in chronic liver disease. The aim of this study was to determine the prevalence of zinc deficiency in different…”
Get full text

Long-term continuous entecavir therapy in nucleos(t)ide-naïve chronic hepatitis B patients by Ono, Atsushi, Suzuki, Fumitaka, Kawamura, Yusuke, Sezaki, Hitomi, Hosaka, Tetsuya, Akuta, Norio, Kobayashi, Masahiro, Suzuki, Yoshiyuki, Saitou, Satoshi, Arase, Yasuji, Ikeda, Kenji, Kobayashi, Mariko, Watahiki, Sachiyo, Mineta, Rie, Kumada, Hiromitsu

“…Background & Aims We determined the antiviral potency and viral resistance rate after 4 years of continuous entecavir treatment in patients with chronic…”
Get full text

Effectiveness of tenofovir alafenamide for chronic hepatitis B patients with a poor response to the previously used nucleos(t)ide analogs by Yamashige, Daiki, Hosaka, Tetsuya, Suzuki, Fumitaka, Fujiyama, Shunichiro, Kawamura, Yusuke, Sezaki, Hitomi, Akuta, Norio, Kobayashi, Masahiro, Suzuki, Yoshiyuki, Saitoh, Satoshi, Arase, Yasuji, Ikeda, Kenji, Kobayashi, Mariko, Kumada, Hiromitsu

“…Background Few studies have demonstrated the potency of tenofovir alafenamide (TAF) in patients with poor response to other nucleos(t)ide analogs (NAs)…”
Get full text

Serial changes in liver stiffness and controlled attenuation parameter following direct‐acting antiviral therapy against hepatitis C virus genotype 1b by Ogasawara, Nobuhiko, Kobayashi, Masahiro, Akuta, Norio, Kominami, Yoko, Fujiyama, Shunichiro, Kawamura, Yusuke, Sezaki, Hitomi, Hosaka, Tetsuya, Suzuki, Fumitaka, Saitoh, Satoshi, Suzuki, Yoshiyuki, Arase, Yasuji, Ikeda, Kenji, Kobayashi, Mariko, Kumada, Hiromitsu

“…Little information is available on the impact of direct‐acting antiviral (DAA) therapy on changes in liver fibrosis and steatosis. Liver stiffness (LS) and…”
Get full text

Clearance of hepatitis B surface antigen during long-term nucleot(s)ide analog treatment in chronic hepatitis B: results from a nine-year longitudinal study by Hosaka, Tetsuya, Suzuki, Fumitaka, Kobayashi, Masahiro, Seko, Yuya, Kawamura, Yusuke, Sezaki, Hitomi, Akuta, Norio, Suzuki, Yoshiyuki, Saitoh, Satoshi, Arase, Yasuji, Ikeda, Kenji, Kobayashi, Mariko, Kumada, Hiromitsu

“…Background Clearance of hepatitis B surface antigen (HBsAg) is considered the ultimate goal in chronic hepatitis B treatment. One treatment option is long-term…”
Get full text

Treatment efficacy of diet and exercise program for fatty liver and pretreatment predictors by Akuta, Norio, Kawamura, Yusuke, Fujiyama, Shunichiro, Nakamichi, Kenichi, Saegusa, Eiji, Ogura, Hidetoshi, Kato, Masaki, Doi, Etsuko, Inoue, Naoko, Sezaki, Hitomi, Hosaka, Tetsuya, Kobayashi, Mariko, Saitoh, Satoshi, Arase, Yasuji, Ikeda, Kenji, Suzuki, Yoshiyuki, Kumada, Hiromitsu, Suzuki, Fumitaka

“…Aims Both diet and exercise counseling are recommended for patients with fatty liver, including nonalcoholic fatty liver disease (NAFLD), to achieve weight…”
Get full text

Hepatitis B Core-Related Antigen Stratifies the Risk of Liver Cancer in HBeAg-Negative Patients With Indeterminate Phase by Tseng, Tai-Chung, Hosaka, Tetsuya, Liu, Chun-Jen, Suzuki, Fumitaka, Hong, Chun-Ming, Kumada, Hiromitsu, Yang, Wan-Ting, Hsu, Chen-Yang, Su, Tung-Hung, Yang, Hung-Chih, Liu, Chen-Hua, Chen, Pei-Jer, Chen, Hsiu-Hsi, Kao, Jia-Horng

“…Many patients with chronic hepatitis B (CHB) are classified as indeterminate patients because they fall outside the defined CHB phases. We aimed to explore…”
Get full text

Myocardial ischemia due to radical resection of complex coronary fistulas with giant aneurysms: a case report by Maeba, Satoru, Sunada, Masatoshi, Ito, Takuya, Suzuki, Fumitaka

“…A 56-year-old man underwent surgery for complex coronary artery fistulas with giant coronary aneurysms. This treatment resulted in complications and caused…”
Get full text

Efficacy and Safety of Ramucirumab in Patients with Unresectable Hepatocellular Carcinoma with Progression after Treatment with Lenvatinib by Kasuya, Kayoko, Kawamura, Yusuke, Kobayashi, Masahiro, Shindoh, Junichi, Kobayashi, Yuta, Kajiwara, Akira, Iritani, Soichi, Fujiyama, Shunichiro, Hosaka, Tetsuya, Saitoh, Satoshi, Sezaki, Hitomi, Akuta, Norio, Suzuki, Fumitaka, Suzuki, Yoshiyuki, Ikeda, Kenji, Arase, Yasuji, Eguchi, Yuichiro, Hashimoto, Masaji, Kumada, Hiromitsu

“…Objective A survival benefit was demonstrated for ramucirumab (RAM) in patients with unresectable hepatocellular carcinoma (uHCC) and α-fetoprotein (AFP)…”
Get full text

Advantage of liver stiffness measurement before and after direct‐acting antiviral therapy to predict hepatocellular carcinoma and exacerbation of esophageal varices in chronic hepatitis C by Ogasawara, Nobuhiko, Saitoh, Satoshi, Akuta, Norio, Sezaki, Hitomi, Suzuki, Fumitaka, Fujiyama, Shunichiro, Kawamura, Yusuke, Hosaka, Tetsuya, Kobayashi, Masahiro, Suzuki, Yoshiyuki, Arase, Yasuji, Ikeda, Kenji, Kumada, Hiromitsu

“…Aim The risk of development of hepatocellular carcinoma (HCC) persisted in patients with advanced fibrosis, even after achieving sustained virologic response…”
Get full text

Potential of ultra‐highly sensitive immunoassays for hepatitis B surface and core‐related antigens in patients with or without development of hepatocellular carcinoma after hepatitis B surface antigen seroclearance by Suzuki, Fumitaka, Hosaka, Tetsuya, Imaizumi, Masayasu, Kobayashi, Mariko, Ohue, Chiharu, Suzuki, Yoshiyuki, Fujiyama, Shunichiro, Kawamura, Yusuke, Sezaki, Hitomi, Akuta, Norio, Kobayashi, Masahiro, Saitoh, Satoshi, Arase, Yasuji, Ikeda, Kenji, Kumada, Hiromitsu

“…Aims Hepatitis B surface antigen (HBsAg) seroclearance indicates a “functional cure” in chronic hepatitis B (CHB) virus infection. However, several cases of…”
Get full text

Abiotrophia defectiva Endocarditis: A Case Diagnosed Incidentally Due to Multi-organ Embolism by Suzuki, Fumitaka, Tsutsui, Masahiro, Isa, Hideki, Kunioka, Shingo, Kamiya, Hiroyuki

“…, often referred to as nutritionally variant streptococci, is generally a benign part of human microflora, primarily found in the oral cavity, digestive tract,…”
Get full text

Nationwide prospective and retrospective surveys for hepatitis B virus reactivation during immunosuppressive therapies by Mochida, Satoshi, Nakao, Masamitsu, Nakayama, Nobuaki, Uchida, Yoshihito, Nagoshi, Sumiko, Ido, Akio, Mimura, Toshihide, Harigai, Masayoshi, Kaneko, Hiroshi, Kobayashi, Hiroko, Tsuchida, Tetsuya, Suzuki, Hiromichi, Ura, Nobuyuki, Nakamura, Yuichi, Bessho, Masami, Dan, Kazuo, Kusumoto, Shigeru, Sasaki, Yasutsuna, Fujii, Hirofumi, Suzuki, Fumitaka, Ikeda, Kenji, Yamamoto, Kazuhiko, Takikawa, Hajime, Tsubouchi, Hirohito, Mizokami, Masashi

“…Background The significance of HBV reactivation during immunosuppressive therapy was evaluated in three nationwide cohorts including patients with previously…”
Get full text